HUM.NYSEHumana INC

Form 4: Humana Director Feinberg Acquires Additional Stock Units Through Deferred Compensation and Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


David T. Feinberg, a director at Humana Inc., increased his holdings through the acquisition of restricted stock units (RSUs) via deferred director fees and dividend reinvestments.

Summary

  • On June 28, 2024, David T. Feinberg, a director of Humana Inc., acquired additional restricted stock units (RSUs).
  • These acquisitions stem from the annual director's fee payable in stock units, director's cash fee elected to be converted into stock units, and dividend payments reinvested into stock units.
  • Feinberg now directly owns 239 restricted stock units acquired on June 28, 2024, at a price of $379.285 per unit.
  • He also holds 441 shares of Humana common stock directly.
  • Additionally, he holds 380, 3, and 430 restricted stock units from previous grants.
  • The restricted stock units represent a contingent right to receive one share of Humana Inc. common stock each, with 100% of the award vesting on December 31, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports transactions related to director compensation. The director's decision to take compensation in stock is a mildly positive signal.

Positives

  • The director's decision to take fees in stock and reinvest dividends signals confidence in Humana's future performance.

Future Outlook

The director's deferred stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, indicating future stock dilution as these units vest.

Industry Context

Form 4 filings are routine disclosures, but they provide insights into the actions and sentiment of company insiders. Director stock acquisitions can be viewed positively by investors.

Comparison to Industry Standards

  • Director compensation in the form of stock and stock options is a common practice among publicly traded companies, aligning management's interests with those of shareholders.
  • Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize stock-based compensation for their directors and executives.

Stakeholder Impact

  • The acquisition of stock units by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
06/28/2024Date of transaction: Acquisition of restricted stock units.
12/31/2024Vesting date for 100% of the 430 restricted stock units.
07/02/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.